The search for undiagnosed MODY patients: What is the next step?

Diabetologia

Volumn 53, Issue 12, 2010, Pages 2465-2467

  Malecki, M T ^a  

^a UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

Author keywords

Diabetes; Differential diagnosis; MODY; Monogenic disease

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; INSULIN; SULFONYLUREA;

AUTOSOMAL DOMINANT INHERITANCE; BODY WEIGHT; CONTINUING EDUCATION; DIET THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; MATURITY ONSET DIABETES MELLITUS; NOTE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; UNITED KINGDOM;

DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES;

EID: 78649329264     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1908-4     Document Type: Note

References (28)

1. MI McCarthy AT Hattersley 2008 Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes Diabetes 57 2889 2898 1:CAS:528:DC%2BD1MXhsleju74%3D 10.2337/db08-0343 18971436
2. R Murphy S Ellard AT Hattersley 2008 Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes Nat Clin Pract Endocrinol Metab 4 200 213 1:CAS:528:DC%2BD1cXjsFClurY%3D 10.1038/ncpendmet0778 18301398 (Pubitemid 351430925)
3. M Vaxillaire A Bonnefond P Froguel 2009 Breakthroughs in monogenic diabetes genetics: from pediatric forms to young adulthood diabetes Pediatr Endocrinol Rev 6 405 417 19396026
4. P Froguel H Zouali N Vionnet, et al. 1993 Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus N Engl J Med 328 697 702 1:STN:280:DyaK3s7msFSqsA%3D%3D 10.1056/NEJM199303113281005 8433729 (Pubitemid 23073372)
5. GI Bell KS Xiang MV Newman, et al. 1991 Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q Proc Natl Acad Sci U S A 88 1484 1488 1:CAS:528:DyaK3MXhtlOhtr8%3D 10.1073/pnas.88.4.1484 1899928
6. PJ Cammidge 1928 Diabetes mellitus and heredity BMJ 2 738 741 10.1136/bmj.2.3538.738 20774217
7. RB Tattersall SS Fajans 1975 A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people Diabetes 24 44 53 1:STN:280:DyaE2M7ksVOltQ%3D%3D 10.2337/diabetes.24.1.44 1122063
8. RB Tattersall PI Mansell 1991 Maturity onset-type diabetes of the young (MODY): one condition or many? Diabet Med 8 402 410 1:STN:280: DyaK3Mzhs12guw%3D%3D 10.1111/j.1464-5491.1991.tb01623.x 1830523
9. AT Hattersley 1998 Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity Diabet Med 15 15 24 1:STN:280:DyaK1c7jt1ajsw%3D%3D 10.1002/(SICI)1096-9136(199801)15:1<15::AID- DIA562>3.0.CO;2-M 9472859 (Pubitemid 28113994)
10. SS Fajans GI Bell KS Polonsky 2001 Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young N Engl J Med 345 971 980 1:CAS:528:DC%2BD3MXntlehtbg%3D 10.1056/NEJMra002168 11575290
11. AT Hattersley 2005 Molecular genetics goes to the diabetes clinic Clin Med 5 476 481 16268330
12. MT Malecki W Mlynarski J Skupien 2008 Can geneticists help clinicians to understand and treat non-autoimmune diabetes? Diabetes Res Clin Pract 82 Suppl 2 S83 S93 10.1016/j.diabres.2008.09.020 19010562
13. ER Pearson BJ Starkey RJ Powell FM Gribble PM Clark AT Hattersley 2003 Genetic cause of hyperglycaemia and response to treatment in diabetes Lancet 362 1275 1281 1:CAS:528:DC%2BD3sXot1Cjt7s%3D 10.1016/S0140-6736(03)14571-0 14575972 (Pubitemid 37324255)
14. M Shepherd B Shields S Ellard O Rubio-Cabezas AT Hattersley 2009 A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients Diabet Med 26 437 441 1:CAS:528:DC%2BD1MXlslClsL0%3D 10.1111/j.1464-5491.2009.02690.x 19388975
15. S Schnyder PE Mullis S Ellard AT Hattersley CE Flück 2005 Genetic testing for glucokinase mutations in clinically selected patients with MODY: a worthwhile investment Swiss Med Wkly 135 352 356 1:CAS:528:DC%2BD2MXpsVaqsL4%3D 16059790
16. BM Shields S Hicks MH Shepherd K Colclough AT Hattersley S Ellard 2010 Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia doi: 10.1007/s00125-010-1799-4
17. AS Slingerland BM Shields SE Flanagan, et al. 2009 Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births Diabetologia 52 1683 1685 1:STN:280:DC%2BD1MvotVGgsw%3D%3D 10.1007/s00125-009-1416-6 19499210
18. J Stanik D Gasperikova M Paskova, et al. 2007 Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers J Clin Endocrinol Metab 92 1276 1282 1:CAS:528:DC%2BD2sXksVSrsbg%3D 10.1210/jc.2006-2490 17213273 (Pubitemid 46556398)
19. E Schober B Rami M Grabert, et al. 2009 Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database Diabet Med 26 466 473 1:CAS:528:DC%2BD1MXnvVWku74%3D 10.1111/j.1464-5491.2009.02720.x 19646184
20. SA Eide H Raeder S Johansson, et al. 2008 Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study) Diabet Med 25 775 781 1:CAS:528:DC%2BD1cXpvFyitbc%3D 10.1111/j.1464-5491.2008.02459.x 18513305
21. Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group 2008 Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young Diabetologia 51 546 553 10.1007/s00125-008-0942-y
22. DG Hert CP Fredlake AE Barron 2008 Advantages and limitations of next-generation sequencing technologies: a comparison of electrophoresis and non-electrophoresis methods Electrophoresis 29 4618 4626 1:CAS:528: DC%2BD1MXhtl2ktQ%3D%3D 10.1002/elps.200800456 19053153
23. Owen KR, Skupien J, Malecki MT; CEED3 Consortium 2009 The clinical application of non-genetic biomarkers for differential diagnosis of monogenic diabetes Diabetes Res Clin Pract 86 Suppl 1 S15 S21
24. S Richter DQ Shih ER Pearson, et al. 2003 Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1α: haploinsufficiency is associated with reduced serum apolipoprotein M levels Diabetes 52 2989 2995 1:CAS:528:DC%2BD3sXpsFagsbY%3D 10.2337/diabetes.52.12.2989 14633861 (Pubitemid 37466870)
25. J Skupien S Gorczynska-Kosiorz T Klupa, et al. 2008 Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1α maturity-onset diabetes of the young Diabetes Care 31 1496 1501 1:CAS:528:DC%2BD1cXhtVWlurrN 10.2337/dc07-2334 18492944
26. A Pal AJ Farmer C Dudley, et al. 2010 Evaluation of serum 1,5-anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes Diabetes Care 33 252 257 1:CAS:528:DC%2BC3cXitlalsbw%3D 10.2337/dc09-1246 19933992
27. J Skupien G Kepka S Gorczynska-Kosiorz, et al. 2007 Evaluation of apolipoprotein M serum concentration as a biomarker of HNF-1alpha MODY Rev Diabet Stud 4 231 235 10.1900/RDS.2007.4.231 18338076
28. C Cervin O Axler J Holmkvist, et al. 2010 An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA J Intern Med 267 316 321 1:CAS:528:DC%2BC3cXjtFOgtbk%3D 10.1111/j.1365-2796.2009.02145.x 19754856